However, contrary observations have been reported in animal models of AD where reduced insulin/IGF-1 signaling through IR/IGF1R and IRS2 slowed the progression of neurodegeneration, suggesting IRS2 action is a negative regulator of cognition/dementia56. Here, IGF1 is linked to Alzheimer disease.